Smith & Nephew plc (SNN)
-NYSE | Prev Close: | 59.90 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 58.82 |
|---|
| Beta: | 0.73 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 47.64 - 60.33 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 53,903 |
|---|
| Market Cap: | 10.84B |
|---|
| P/E (ttm): | 15.18 |
|---|
| EPS (ttm): | 3.95 |
|---|
| Div & Yield: | 1.58 (2.70%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Gloomy Prospects For Medical Device Companiesat Seeking Alpha(Sun, Jun 16)
- Can These Acquisitions Cure This Sales Slump?at Motley Fool(Sat, Jun 8)
- Why I Own Intuitive Surgicalat Motley Fool(Wed, May 29)
- 4 Stocks Underperforming Today In The Health Services Industryat TheStreet(Fri, May 17)
- SNN Sales Beat but Earnings Miss on Weak ResultsZacks(Mon, May 6)
- Emerging Markets Heat Up for Device Makersat Motley Fool(Sat, May 4)
- Profits Drop 4% at Smith & Nephewat Motley Fool(Thu, May 2)
- Bottom-Up Stock Selection to Find Growth at a Reasonable Price: Which High-Quality Stocks Can You Add to the Core of Your Portfolio to Strengthen and Growth It?Wall Street Transcript(Thu, May 2)
- Smith & Nephew Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 2)
- Top 5 Stocks Using GARP And YARP In Search Of Relatively Good Dividend Income Total Returnat Seeking Alpha(Sun, Apr 28)
- Zimmer Beats Earnings, Misses RevenueZacks(Thu, Apr 25)
- What Will It Take For Stem Cell Companies To Close The Valuation Gap?at Seeking Alpha(Wed, Apr 17)
- SNN Ex-Dividend Reminder - 4/17/13at Forbes(Mon, Apr 15)
- Wound Care Market: The Promise Of Healingat Seeking Alpha(Sat, Apr 13)
- Should You Buy Smith & Nephew Today?at Motley Fool(Fri, Apr 12)
Key Statistics
| Forward P/E (1 yr): | 14.16 |
|---|
| P/S (ttm): | 2.62 |
|---|
| Ex-Dividend Date: | 17-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.87 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.93 |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | 1.96 |
|---|
Business Summary
Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide.
View More 
0.91%